In addition, PSP was found to be significantly elevated in patients presenting with severe COVID-19, and levels above 775 pg/mL were significantly associated with in-hospital mortality (sensitivity 73% and specificity 80%) [67]. This evidence concerns the gene REG1A and COVID-19.